Cargando…

SAT-027 Comparison of Estradiol by Mass Spectrometry Versus Immunoassay in Women Undergoing Menopause: Study of Womens Health Across the Nation (SWAN)

Serum estradiol (E2) concentrations in midreproductive women are easily measured using a variety of conventional immunoassays (IA). However, when women approach and traverse menopause, E2 eventually drops below levels where IA lacks sufficient sensitivity to accurately measure E2. Liquid chromatogra...

Descripción completa

Detalles Bibliográficos
Autores principales: Santoro, Nanette F, Auchus, Richard Joseph, Greendale, Gail, Lasley, Bill L, McConnell, Daniel S, Randolph, John F, Martin, Deborah, Crawford, Sybil
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7209686/
http://dx.doi.org/10.1210/jendso/bvaa046.446
_version_ 1783531136309264384
author Santoro, Nanette F
Auchus, Richard Joseph
Greendale, Gail
Lasley, Bill L
McConnell, Daniel S
Randolph, John F
Martin, Deborah
Crawford, Sybil
author_facet Santoro, Nanette F
Auchus, Richard Joseph
Greendale, Gail
Lasley, Bill L
McConnell, Daniel S
Randolph, John F
Martin, Deborah
Crawford, Sybil
author_sort Santoro, Nanette F
collection PubMed
description Serum estradiol (E2) concentrations in midreproductive women are easily measured using a variety of conventional immunoassays (IA). However, when women approach and traverse menopause, E2 eventually drops below levels where IA lacks sufficient sensitivity to accurately measure E2. Liquid chromatography and tandem mass spectrometry (LC/MS/MS) has become the standard method for assessing steroid hormones, especially when circulating concentrations are low. We evaluated the relationship between IA and LC/MS/MS E2 measurements in a cohort of women taken from the Study of Womens Health Across the Nation (SWAN) to assess the degree of agreement between the two methods and to determine the level of E2 at which IA becomes unreliable. Methods: 315 serum samples that had been previously measured for E2 using IA were re-analyzed using LC/MS/MS performed by one of the authors (RA). In this original set, E2 levels that were below the limit of assay detection (LLD, 6 pg/ml) were interpolated as a random number between 0 and the LLD. Agreement between all 315 samples was assessed using both Pearson and Spearman correlation. The analysis was repeated excluding the subset of specimens that were below the lower limit of detection (LLD) for the IA E2 assay (6 pg/ml; N=176), and a third set of correlations was obtained for specimens that measured <15 pg/ml by IA but were above the 6 pg/ml LLD (N=82). Results: The overall dataset (N=315) demonstrated excellent agreement between IA and LC/MS/MS with a Pearson’s r and Spearmans r of 0.98 AND 0.60, respectively. When the subset of 176 samples above the LLD were assessed, Pearson’s r was 0.98 and Spearman’s r was 0.81. In contrast, when specimens measuring 6–15 pg/ml by IA were compared to LC/MS/MS, Pearson’s r was -0.03 and Spearman’s r was 0.09, indicating a complete loss of relationship between the two methods. Conclusions: The IA used by SWAN (England, Clin Chem 2002; 48: 1584) and LC/MS/MS demonstrate excellent correlation for E2 measurements above 15 pg/ml. However, circulating concentrations of E2 below 15 pg/ml were not accurately measured using IA.
format Online
Article
Text
id pubmed-7209686
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-72096862020-05-13 SAT-027 Comparison of Estradiol by Mass Spectrometry Versus Immunoassay in Women Undergoing Menopause: Study of Womens Health Across the Nation (SWAN) Santoro, Nanette F Auchus, Richard Joseph Greendale, Gail Lasley, Bill L McConnell, Daniel S Randolph, John F Martin, Deborah Crawford, Sybil J Endocr Soc Reproductive Endocrinology Serum estradiol (E2) concentrations in midreproductive women are easily measured using a variety of conventional immunoassays (IA). However, when women approach and traverse menopause, E2 eventually drops below levels where IA lacks sufficient sensitivity to accurately measure E2. Liquid chromatography and tandem mass spectrometry (LC/MS/MS) has become the standard method for assessing steroid hormones, especially when circulating concentrations are low. We evaluated the relationship between IA and LC/MS/MS E2 measurements in a cohort of women taken from the Study of Womens Health Across the Nation (SWAN) to assess the degree of agreement between the two methods and to determine the level of E2 at which IA becomes unreliable. Methods: 315 serum samples that had been previously measured for E2 using IA were re-analyzed using LC/MS/MS performed by one of the authors (RA). In this original set, E2 levels that were below the limit of assay detection (LLD, 6 pg/ml) were interpolated as a random number between 0 and the LLD. Agreement between all 315 samples was assessed using both Pearson and Spearman correlation. The analysis was repeated excluding the subset of specimens that were below the lower limit of detection (LLD) for the IA E2 assay (6 pg/ml; N=176), and a third set of correlations was obtained for specimens that measured <15 pg/ml by IA but were above the 6 pg/ml LLD (N=82). Results: The overall dataset (N=315) demonstrated excellent agreement between IA and LC/MS/MS with a Pearson’s r and Spearmans r of 0.98 AND 0.60, respectively. When the subset of 176 samples above the LLD were assessed, Pearson’s r was 0.98 and Spearman’s r was 0.81. In contrast, when specimens measuring 6–15 pg/ml by IA were compared to LC/MS/MS, Pearson’s r was -0.03 and Spearman’s r was 0.09, indicating a complete loss of relationship between the two methods. Conclusions: The IA used by SWAN (England, Clin Chem 2002; 48: 1584) and LC/MS/MS demonstrate excellent correlation for E2 measurements above 15 pg/ml. However, circulating concentrations of E2 below 15 pg/ml were not accurately measured using IA. Oxford University Press 2020-05-08 /pmc/articles/PMC7209686/ http://dx.doi.org/10.1210/jendso/bvaa046.446 Text en © Endocrine Society 2020. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Reproductive Endocrinology
Santoro, Nanette F
Auchus, Richard Joseph
Greendale, Gail
Lasley, Bill L
McConnell, Daniel S
Randolph, John F
Martin, Deborah
Crawford, Sybil
SAT-027 Comparison of Estradiol by Mass Spectrometry Versus Immunoassay in Women Undergoing Menopause: Study of Womens Health Across the Nation (SWAN)
title SAT-027 Comparison of Estradiol by Mass Spectrometry Versus Immunoassay in Women Undergoing Menopause: Study of Womens Health Across the Nation (SWAN)
title_full SAT-027 Comparison of Estradiol by Mass Spectrometry Versus Immunoassay in Women Undergoing Menopause: Study of Womens Health Across the Nation (SWAN)
title_fullStr SAT-027 Comparison of Estradiol by Mass Spectrometry Versus Immunoassay in Women Undergoing Menopause: Study of Womens Health Across the Nation (SWAN)
title_full_unstemmed SAT-027 Comparison of Estradiol by Mass Spectrometry Versus Immunoassay in Women Undergoing Menopause: Study of Womens Health Across the Nation (SWAN)
title_short SAT-027 Comparison of Estradiol by Mass Spectrometry Versus Immunoassay in Women Undergoing Menopause: Study of Womens Health Across the Nation (SWAN)
title_sort sat-027 comparison of estradiol by mass spectrometry versus immunoassay in women undergoing menopause: study of womens health across the nation (swan)
topic Reproductive Endocrinology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7209686/
http://dx.doi.org/10.1210/jendso/bvaa046.446
work_keys_str_mv AT santoronanettef sat027comparisonofestradiolbymassspectrometryversusimmunoassayinwomenundergoingmenopausestudyofwomenshealthacrossthenationswan
AT auchusrichardjoseph sat027comparisonofestradiolbymassspectrometryversusimmunoassayinwomenundergoingmenopausestudyofwomenshealthacrossthenationswan
AT greendalegail sat027comparisonofestradiolbymassspectrometryversusimmunoassayinwomenundergoingmenopausestudyofwomenshealthacrossthenationswan
AT lasleybilll sat027comparisonofestradiolbymassspectrometryversusimmunoassayinwomenundergoingmenopausestudyofwomenshealthacrossthenationswan
AT mcconnelldaniels sat027comparisonofestradiolbymassspectrometryversusimmunoassayinwomenundergoingmenopausestudyofwomenshealthacrossthenationswan
AT randolphjohnf sat027comparisonofestradiolbymassspectrometryversusimmunoassayinwomenundergoingmenopausestudyofwomenshealthacrossthenationswan
AT martindeborah sat027comparisonofestradiolbymassspectrometryversusimmunoassayinwomenundergoingmenopausestudyofwomenshealthacrossthenationswan
AT crawfordsybil sat027comparisonofestradiolbymassspectrometryversusimmunoassayinwomenundergoingmenopausestudyofwomenshealthacrossthenationswan